Marimed (MRMD) Profit After Tax (2011 - 2026)

Marimed (MRMD) has 16 years of Profit After Tax data on file, last reported at -$3.8 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at -$3.8 million, up 30.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.8 million (up 22.67% YoY), and the FY2025 annual result was -$14.5 million, down 16.18% from the prior year.
• Profit After Tax climbed to -$3.8 million in Q1 2026 per MRMD's latest filing, from -$4.7 million in the prior quarter.
• Over five years, Profit After Tax peaked at $4.8 million in Q4 2022 and troughed at -$10.2 million in Q4 2023.
• A 5-year average of -$2.0 million and a median of -$1.4 million in 2024 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax surged 173.06% in 2022, then plunged 313.73% in 2023.
• A 5-year view of Profit After Tax shows it stood at $4.8 million in 2022, then sank by 313.73% to -$10.2 million in 2023, then increased by 18.32% to -$8.3 million in 2024, then soared by 43.75% to -$4.7 million in 2025, then gained by 18.93% to -$3.8 million in 2026.
• Business Quant data shows MRMD's Profit After Tax at -$3.8 million in Q1 2026, -$4.7 million in Q4 2025, and -$2.9 million in Q3 2025.